Monday, April 15

1:40 pm - 2:30 pm


Neurosurgery in Press: Latest Results of Clinical Trials in Neurosurgery and Allied Fields

AANS Member Fee: $65
Non-member Fee: $65
Member Fee: $65

Director(s): Frederick G. Barker II, MD, FAANS

Assistant Director(s): Aviva Abosch, MD, PhD, FAANS

Faculty: Sepideh Amin-Hanjani, MD, FAANS; Daniel P. Cahill, MD, PhD, FAANS; Zoher Ghogawala, MD, FAANS; Uzma Samadani, MD, PhD, FAANS

As neurosurgeons practice increasingly as part of multidisciplinary teams, major clinical advances are sometimes reported first at meetings other than the AANS Annual Scientific Meeting. Vital information for daily neurosurgical practice might be reported at a general oncology meeting, a stroke meeting in Europe or an orthopedic spine meeting. Few neurosurgeons can attend every important allied meeting even within one narrow subspecialty, and none can keep abreast of all of the fields that make up modern neurosurgery. Yet these new advances can be central to neurosurgical practice. In this session, section experts have combed the previous year’s allied-specialty meetings across the globe for important clinical trial advances every neurosurgeon should know - about brain tumors, interventional vascular techniques, spine techniques and more. Key findings are placed in context for both practicing neurosurgeons and residents in this lunchtime session.

Learning Objectives: After completing this educational activity, participants should be able to:
  • Review important advances relevant to neurosurgical clinical practice that were reported at major medical meetings (other than the AANS and CNS) during the last year.
  • Apply these findings in the context of existing practice.
  • Highlight ongoing trials in allied clinical fields – where neurosurgery is headed in the future.